{"id":30761,"date":"2025-02-19T14:03:00","date_gmt":"2025-02-19T13:03:00","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/info-communication\/news\/information-webinar-messidore-2025-programme\/"},"modified":"2025-10-01T13:59:33","modified_gmt":"2025-10-01T12:59:33","slug":"information-webinar-messidore-2025-programme","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/","title":{"rendered":"Information webinar &#8211; MESSIDORE 2025 programme"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"767\" height=\"250\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-1.png\" alt=\"\" class=\"wp-image-30053\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-1.png 767w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-1-300x98.png 300w\" sizes=\"(max-width: 767px) 100vw, 767px\" \/><\/figure>\n\n<p><\/p>\n\n<p>The IReSP is organising an <strong>information webinar<\/strong> on <strong>Friday 7 March 2025<\/strong> to present the <strong>MESSIDORE 2025 call for projects<\/strong>. This programme aims to support innovative projects in clinical trial methodology, primary care trials, medical devices and the use of health data and biobanks.<\/p>\n\n<p>The AAP is aimed at research teams (including at least one <strong>Inserm<\/strong> team) working in collaboration with healthcare providers, focusing on <strong>two areas<\/strong>:<\/p>\n\n<ul>\n<li><strong>Axis 1<\/strong>: Innovative clinical trials, primary care trials and medical devices<\/li>\n\n\n\n<li><strong>Axis 2<\/strong>: Studies using health data or biobanks<\/li>\n<\/ul>\n\n<p>This session will present the evolution of the <strong>MESSIDORE<\/strong> programme, in particular the transition <strong>from <\/strong>the <strong>two-phase selection procedure<\/strong>:<\/p>\n\n<ul>\n<li><strong>Phase 1<\/strong>: Pre-selection based on a letter of intent (to be submitted by <strong>11 April 2025<\/strong>)<\/li>\n\n\n\n<li><strong>Phase 2<\/strong>: Final selection based on complete documentation for shortlisted projects<\/li>\n<\/ul>\n\n<p><\/p>\n\n<p><strong>Webinar programme<\/strong><\/p>\n\n<p>\ud83d\udd65 <strong>Presentation<\/strong><\/p>\n\n<ul>\n<li>Presentation of Inserm and <strong>IReSP<\/strong><\/li>\n\n\n\n<li>Presentation of the <strong>MESSIDORE<\/strong> programme and call for projects<\/li>\n<\/ul>\n\n<p><strong>\ud83d\udccc Details about the call for projects:<\/strong><\/p>\n\n<ul>\n<li><strong>Calendar<\/strong>: key dates in the selection process<\/li>\n\n\n\n<li><strong>Application procedure<\/strong>: application requirements and submission via the EVA3 platform<\/li>\n\n\n\n<li><strong>Selection process<\/strong>: eligibility criteria, exclusion criteria and scientific evaluation<\/li>\n\n\n\n<li><strong>Funding<\/strong>: amounts and project duration<\/li>\n\n\n\n<li><strong>Monitoring of successful projects<\/strong>: agreements, deliverables, promotion of results<\/li>\n<\/ul>\n\n<p>\ud83d\udd0e <strong>Questions and Answers<\/strong>&#13;\nThere will be time set aside for a live Q&amp;A session. Questions requiring in-depth analysis can be sent to <strong><a href=\"mailto:messidore@inserm.fr\">messidore@inserm.fr<\/a><\/strong> after the session.<\/p>\n\n<p><strong>Practical information<\/strong> \ud83d\udcc5 <strong>Date:<\/strong> Friday, 7 March 2025&#13;\n\ud83d\udd58 <strong>Time:<\/strong> 2:00 p.m. to 3:30 p.m.&#13;\n\ud83d\udccd <strong>Format:<\/strong> Online \u2013 <a href=\"https:\/\/events.teams.microsoft.com\/event\/35e9cbc0-511d-47b8-ac94-4e1e47da61b3@99dde8fb-92f6-414d-bc5e-44ffa3e2419c\">Click here to register<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The IReSP is organising an information webinar on Friday 7 March 2025 to present the MESSIDORE 2025 call for projects. This programme aims to support innovative projects in clinical trial methodology, primary care trials, medical devices and the use of health data and biobanks. The AAP is aimed at research teams (including at least one [&hellip;]<\/p>\n","protected":false},"author":280,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[58],"tags":[6758,6761],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Information webinar - MESSIDORE 2025 programme - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Information webinar - MESSIDORE 2025 programme - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-19T13:03:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-01T12:59:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-1.png\" \/>\n<meta name=\"author\" content=\"Kevin Gr\u00e9goire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kevin Gr\u00e9goire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/\"},\"author\":{\"name\":\"Kevin Gr\u00e9goire\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700\"},\"headline\":\"Information webinar &#8211; MESSIDORE 2025 programme\",\"datePublished\":\"2025-02-19T13:03:00+00:00\",\"dateModified\":\"2025-10-01T12:59:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/\"},\"wordCount\":238,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-1.png\",\"keywords\":[\"AAP\",\"Webinar\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/\",\"name\":\"Information webinar - MESSIDORE 2025 programme - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-1.png\",\"datePublished\":\"2025-02-19T13:03:00+00:00\",\"dateModified\":\"2025-10-01T12:59:33+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-1.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-1.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Information webinar \u2013 MESSIDORE 2025 programme\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700\",\"name\":\"Kevin Gr\u00e9goire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Information webinar - MESSIDORE 2025 programme - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/","og_locale":"en_GB","og_type":"article","og_title":"Information webinar - MESSIDORE 2025 programme - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2025-02-19T13:03:00+00:00","article_modified_time":"2025-10-01T12:59:33+00:00","og_image":[{"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-1.png"}],"author":"Kevin Gr\u00e9goire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Kevin Gr\u00e9goire","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/"},"author":{"name":"Kevin Gr\u00e9goire","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700"},"headline":"Information webinar &#8211; MESSIDORE 2025 programme","datePublished":"2025-02-19T13:03:00+00:00","dateModified":"2025-10-01T12:59:33+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/"},"wordCount":238,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-1.png","keywords":["AAP","Webinar"],"articleSection":["News"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/","name":"Information webinar - MESSIDORE 2025 programme - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-1.png","datePublished":"2025-02-19T13:03:00+00:00","dateModified":"2025-10-01T12:59:33+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-1.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/image-1.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/information-webinar-messidore-2025-programme\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"Information webinar \u2013 MESSIDORE 2025 programme"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/3bec06f8a90e180a3ba8957cae88c700","name":"Kevin Gr\u00e9goire"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-26 21:16:28","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/30761"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/280"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=30761"}],"version-history":[{"count":3,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/30761\/revisions"}],"predecessor-version":[{"id":30764,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/30761\/revisions\/30764"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=30761"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=30761"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=30761"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}